United States · FDA National Drug Code directory
calcipotriene and betamethasone dipropionate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0713-0848_1f935790-9208-96ae-e063-6294a90ae07c
- Product NDC
- 0713-0848
- Form
- SUSPENSION
- Composition / generic term
- calcipotriene and betamethasone dipropionate
- Labeler
- Cosette Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240802
- Source listing expiry
- 20261231
Source-listed ingredients
- BETAMETHASONE DIPROPIONATE — .5 mg/g
- CALCIPOTRIENE — 50 ug/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0713-0848-60) / 60 g in 1 BOTTLE · 0713-0848-60
- 2 BOTTLE in 1 CARTON (0713-0848-92) / 60 g in 1 BOTTLE · 0713-0848-92
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →